IXICO Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
IXICO is forecast to grow earnings and revenue by 5.5% and 1.8% per annum respectively while EPS is expected to grow by 38.7% per annum.
Wichtige Informationen
5.5%
Wachstumsrate der Gewinne
38.7%
EPS-Wachstumsrate
| Life Sciences Gewinnwachstum | 19.8% |
| Wachstumsrate der Einnahmen | 1.8% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 08 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is IXICO plc (LON:IXI) Potentially Undervalued?
Sep 30
Is It Time To Consider Buying IXICO plc (LON:IXI)?
Apr 13If You Like EPS Growth Then Check Out IXICO (LON:IXI) Before It's Too Late
Feb 25Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock
Nov 20Should You Think About Buying IXICO plc (LON:IXI) Now?
Oct 25Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock
Aug 11Here's Why I Think IXICO (LON:IXI) Is An Interesting Stock
Apr 17IXICO plc (LON:IXI) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Mar 24At UK£1.04, Is It Time To Put IXICO plc (LON:IXI) On Your Watch List?
Mar 22Does IXICO's (LON:IXI) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 22Did Business Growth Power IXICO's (LON:IXI) Share Price Gain of 146%?
Feb 01
Will Weakness in IXICO plc's (LON:IXI) Stock Prove Temporary Given Strong Fundamentals?
Jan 09I Ran A Stock Scan For Earnings Growth And IXICO (LON:IXI) Passed With Ease
Dec 22Who Has Been Selling IXICO plc (LON:IXI) Shares?
Dec 04What Does IXICO plc's (LON:IXI) Share Price Indicate?
Jul 06Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 9/30/2025 | 6 | -2 | -2 | -2 | 1 |
| 9/30/2024 | 6 | -2 | -2 | -2 | 1 |
| 3/31/2024 | 6 | -2 | -2 | -1 | N/A |
| 12/31/2023 | 6 | -2 | -2 | 0 | N/A |
| 9/30/2023 | 7 | -1 | -2 | 0 | N/A |
| 6/30/2023 | 7 | -1 | -1 | 1 | N/A |
| 3/31/2023 | 8 | 0 | -1 | 1 | N/A |
| 12/31/2022 | 8 | 1 | -1 | 1 | N/A |
| 9/30/2022 | 9 | 1 | -1 | 1 | N/A |
| 6/30/2022 | 8 | 1 | -1 | 1 | N/A |
| 3/31/2022 | 8 | 1 | -1 | 1 | N/A |
| 12/31/2021 | 9 | 1 | -1 | 1 | N/A |
| 9/30/2021 | 9 | 2 | -2 | 1 | N/A |
| 6/30/2021 | 10 | 1 | -1 | 1 | N/A |
| 3/31/2021 | 10 | 1 | 0 | 2 | N/A |
| 12/31/2020 | 10 | 1 | 0 | 2 | N/A |
| 9/30/2020 | 10 | 1 | 1 | 2 | N/A |
| 6/30/2020 | 9 | 1 | 0 | 1 | N/A |
| 3/31/2020 | 9 | 1 | -1 | 0 | N/A |
| 12/31/2019 | 8 | 1 | -1 | 0 | N/A |
| 9/30/2019 | 8 | 0 | -1 | 0 | N/A |
| 6/30/2019 | 7 | 0 | -1 | 0 | N/A |
| 3/31/2019 | 6 | 0 | 0 | 0 | N/A |
| 12/31/2018 | 6 | 0 | 0 | 0 | N/A |
| 9/30/2018 | 5 | -1 | 0 | 0 | N/A |
| 6/30/2018 | 5 | -1 | N/A | N/A | N/A |
| 3/31/2018 | 5 | -1 | 0 | 0 | N/A |
| 12/31/2017 | 4 | -1 | N/A | 0 | N/A |
| 9/30/2017 | 4 | -2 | N/A | -1 | N/A |
| 6/30/2017 | 4 | -2 | N/A | N/A | N/A |
| 3/31/2017 | 4 | -2 | N/A | 0 | N/A |
| 12/31/2016 | 4 | -2 | N/A | -1 | N/A |
| 9/30/2016 | 3 | -2 | N/A | -2 | N/A |
| 6/30/2016 | 3 | -2 | N/A | N/A | N/A |
| 3/31/2016 | 3 | -2 | N/A | -2 | N/A |
| 12/31/2015 | 3 | -1 | N/A | -1 | N/A |
| 9/30/2015 | 3 | -1 | N/A | -1 | N/A |
| 3/31/2015 | 3 | -1 | N/A | -1 | N/A |
| 12/31/2014 | 3 | -1 | N/A | -2 | N/A |
| 9/30/2014 | 3 | -2 | N/A | -2 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: IXI is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: IXI is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: IXI is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: IXI's revenue (1.8% per year) is forecast to grow slower than the UK market (3.6% per year).
Hohe Wachstumseinnahmen: IXI's revenue (1.8% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if IXI's Return on Equity is forecast to be high in 3 years time